GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Loans Receivable

Veritas In Silico (TSE:130A) Loans Receivable : 円0.0 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Loans Receivable?

Veritas In Silico's Loans Receivable for the quarter that ended in Jun. 2024 was 円0.0 Mil.


Veritas In Silico Loans Receivable Historical Data

The historical data trend for Veritas In Silico's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Loans Receivable Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23
Loans Receivable
- - -

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24
Loans Receivable Get a 7-Day Free Trial - - - - -

Veritas In Silico Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Veritas In Silico Loans Receivable Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines